ERA-IB-2

ERA-Net for Industrial Biotechnology 2

 Partecipanti

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The ERA-Net Industrial Biotechnology 2 (ERA-IB-2) will increase Europe’s competitiveness in Industrial Biotechnology (IB) by providing a platform for long-lasting collaboration and cooperation between national/regional programme owners and managers of a large number of European countries, including new Member States and Associated /ICP Countries. The key mission of ERA-IB-2 is to contribute to a European knowledge-based bio-economy (KBBE) by reducing fragmentation in IB R&D funding and by fostering the exchange of knowledge across borders, and to increase cost-effectiveness by pooling resources and optimising mechanisms for joint calls. The KBBE is the tool to achieving sustainable economic growth in Europe, as it will lead to sustainable, environmentally sound industrial processes and products which substitute fossil resources with bio-based (renewable) raw materials. Industrial Biotechnology will be one of the key technologies of this KBBE, and ERA-IB-2 will ensure Europe makes full use of her potential by identifying IB-related R&D needs through stakeholder dialogue and responding to these needs with coordinated, joint actions (joint calls). These calls will lead to greater integration of IB R&D actors and activities, and will also improve access to finance and stimulate industry participation – and thus industry investment – in the lead market of bio-based products. As a consequence, the limited resources of each country will be used more efficiently. ERA-IB-2 builds on the success of the FP6 project “ERA-IB” and develops the network further, into a truly pan-European approach to IB R&D funding which should ultimately lead to a self-sustained network. ERA-IB-2 will also align with other initiatives in the area and e.g. support the developing JPIs by presenting to them the view of the national/regional programmes on IB topics.'

Introduzione (Teaser)

Aiming to increase Europe's competitiveness in the field of industrial biotechnology, the ERA-IB-2 project will provide a platform for long-lasting collaboration and cooperation between different countries. This will not only improve research and development (R&D) in the field but also ensure funding and resources are allocated according to needs.

Descrizione progetto (Article)

The growing need for renewable energy sources to substitute fossil fuels requires a more united European front in the field of industrial biotechnology. This could lead to sustainable, environmentally sound industrial processes and products, and avoid research and funding fragmentation.

Based on this, the key objective of the EU-funded 'ERA-Net for industrial biotechnology 2' (ERA-IB-2) network is to bring European countries together and strengthen the cooperation and coordination of their activities. The ultimate goal is to increase the quality of R&D in industrial biotechnology, to ensure the exchange of knowledge and to improve cost effectiveness by pooling resources. This includes access to European infrastructure.

Various dissemination activities have been organised to introduce the ERA-IB-2 to the wider public and to set up collaborations with other initiatives. The http://www.era-ib.net/ (project website) has been launched along with a social media account for communicating the news of the project.

Following stakeholder consultation, the partners of the project have identified the priority topics for the first call under ERA-IB-2. Since ERA-IB-2 is a continuation of the previous ERA-IB project, this funding call is the third in the series and was published in March 2012. Out of the 33 submitted proposals, 12 have been prioritised for funding.

The fourth call in February 2013 is concentrated on small and medium-sized enterprises (SMEs) and industrial biotechnology, and is further supported by EUROTRANSBIO, another ERA-Net with funding activities in biotechnology. This is expected to increase country participation and become more attractive to the industry.

By responding to industry needs, the ERA-IB-2 network aims to stimulate industry participation and thus industry investments in the field of biotechnology. Funding of cross-disciplinary, transnational research projects is expected to lead to innovative, marketable and economic solutions for the bioeconomy.